Advancing precision oncology in soft tissue sarcomas: The role of iTRAC in metastatic risk stratification and treatment personalization.

Adaptive AI-driven clinical decision-making in oncology through digital twins and large-scale imaging biomarkers. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced major new features for the Guardant ...

Guardant Health, Inc. (NASDAQ:GH) has introduced major upgrades to its Guardant360 Liquid biopsy test, significantly ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a biomarkers in kidney cancer session. Dr.

A novel explainable machine learning model accurately differentiates essential tremor from cortical myoclonus using wearable ...

Explore how early autism traits are nearly identical in boys and girls - find out what this means for early intervention.

The effects of obesity on cancer treatment efficacy remain unclear, as both beneficial and detrimental modulations of the tumor immune microenvironment have been reported. We compared 68Ga-NOTA-GZP ...